Pull to refresh
Logo
ADHD trial finds medication and behavior therapy reduce rule-breaking, but classroom accommodations do not

ADHD trial finds medication and behavior therapy reduce rule-breaking, but classroom accommodations do not

New Capabilities

A randomized study of 255 children found extra time, frequent breaks, standing desks and quiet workspaces did not improve behavior or quiz scores.

Overview

Updated 1 hour ago

For years, extra time on assignments, frequent breaks, standing desks and quiet workspaces have been standard classroom fixes for children with ADHD. A randomized trial of 255 children found none of those accommodations improved classroom behavior or quiz scores, even when combined with medication or behavior therapy.

The trial did find that stimulant medication and behavioral therapy reduced rule-breaking. It ran in a controlled summer treatment program and excluded children with low IQ or autism, so the authors and outside experts say the results need testing in ordinary classrooms.

Why it matters

If the findings hold, schools may need to shift ADHD support from generic accommodations toward behavior coaching and medication.

Questions about this story

Free account needed to ask — your question is kept and asked for you right after sign-up. Answers are public.

No questions yet — be the first to ask.

Key Indicators

255
Children in trial
Kindergarten through sixth grade; 235 completed the study.
61%
Rule-violation reduction with stimulant medication
Compared with no medication, as summarized by Florida International University.
37%
Rule-violation reduction with behavioral intervention
Compared with a general classroom, as summarized by Florida International University.
4
Accommodations tested
Extended time, frequent breaks, a low-distraction workspace and a standing desk.
0
Accommodations with a significant effect
No significant improvement in behavior or academic outcomes.
22%
Increase in seatwork productivity with medication
Rate ratio 1.22 versus placebo.

Voices

Curated perspectives — historical figures and your fellow readers.

Sign up to generate historical perspectives on this story.

People Involved

Organizations Involved

Timeline

2022 November 2026

3 events Latest: Yesterday
  1. JAMA Pediatrics publishes trial

    Latest Research

    Results show medication and behavior therapy reduce rule-breaking, while four accommodations do not.

  2. Data analysis begins

    Research

    Researchers analyze trial data from March to July 2026.

  3. Trial enrolls children in FIU summer program

    Research

    Children in kindergarten through sixth grade joined the Summer Treatment Program between 2022 and 2025.

Scenarios

1

Pediatricians update ADHD guidance to favor behavior therapy over generic accommodations

Possible Resolves by End of 2027

Discussed by: FIU News and Science Media Centre commentaries

The trial could push professional groups to revise ADHD practice guidelines. The trigger would be a guideline committee concluding that generic classroom accommodations lack evidence and that behavior therapy or medication should be prioritized.

2

Real-classroom trial replicates the null result for accommodations

Possible Resolves by End of 2028

Discussed by: Study authors and Dr Melanie Woodfield

The current trial ran in a controlled summer program with extra staff. A replication in ordinary classrooms would test whether the same pattern holds when teachers have fewer resources and more students with complex needs.

3

Schools keep common ADHD accommodations in place

Likely Resolves by Nov 14, 2027

Discussed by: FIU News

Accommodations are written into many individualized education programs and Section 504 plans. Changing them requires new guidance, training and paperwork, so the default may be to keep current practice even after the trial.

Historical Context

2 moments from history that rhyme with this story — and how they unfolded.

1999

Multimodal Treatment Study of ADHD (1999)

A landmark U.S. trial compared medication management, behavioral treatment, combined treatment and community care for children with ADHD. It found medication and behavioral therapy each reduced core symptoms, with combined treatment helping in some areas.

Then

It cemented stimulant medication and behavior therapy as evidence-based ADHD treatments.

Now

It set a benchmark for testing ADHD interventions in randomized trials.

Why this matters now

The new trial extends that logic to classroom accommodations, which had been widely used without comparable evidence.

2010

Head Start Impact Study (2010)

The U.S. government randomized children to Head Start or a control group and tracked them through early school. It found early academic benefits that largely faded by third grade.

Then

The results challenged claims that the program alone would close school-readiness gaps.

Now

It became a reference point for rigorous testing of widely used social programs.

Why this matters now

Like the ADHD accommodation trial, it shows why popular supports need randomized tests.

Sources

(4)